vincristine-induced sensory peripheral neuropathy

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)